PubRank

S H Gillespie

Author PubWeight™ 94.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004 4.25
2 Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999 2.91
3 Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax 2002 2.53
4 Quantitative validation of media for transportation and storage of Streptococcus pneumoniae. J Clin Microbiol 2003 2.41
5 Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J 1995 2.39
6 Coagulase-negative methicillin-resistant Staphylococcus aureus infection. Lancet 1993 2.26
7 Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp.? J Clin Microbiol 1995 2.21
8 Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis 1994 2.21
9 Nonrandom association of IS6110 and Mycobacterium tuberculosis: implications for molecular epidemiological studies. J Clin Microbiol 1998 1.94
10 Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis 1993 1.80
11 Methicillin resistant Staphylococcus aureus without clumping factor, protein A, and DNAse. Lancet 1991 1.58
12 Pitfalls of PCR: misdiagnosis of cerebral nocardia infection. Lancet 1995 1.57
13 Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis. Thorax 2007 1.56
14 Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol 2000 1.51
15 IS6110 homologs are present in multiple copies in mycobacteria other than tuberculosis-causing mycobacteria. J Clin Microbiol 1997 1.47
16 Length of time to laboratory diagnosis of Mycobacterium tuberculosis infection: comparison of in-house methods with reference laboratory results. J Infect 1999 1.44
17 Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat? Clin Infect Dis 2003 1.44
18 Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol 2002 1.44
19 Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates. J Clin Microbiol 2001 1.41
20 Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis 1996 1.40
21 Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992 1.39
22 Molecular methods for Mycobacterium tuberculosis strain typing: a users guide. J Appl Microbiol 2003 1.38
23 Counterimmunoelectrophoresis in the diagnosis of whooping cough. J Clin Pathol 1984 1.29
24 Streptococcus mitis and ARDS in neutropenic patients. Lancet 1991 1.28
25 Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax 2005 1.23
26 Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples. J Med Microbiol 2004 1.19
27 Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother 1993 1.18
28 Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg 1996 1.15
29 Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J Infect 2000 1.11
30 Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. J Antimicrob Chemother 2008 1.05
31 Detection of penicillin susceptibility in Streptococcus pneumoniae by pbp2b PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1999 1.05
32 Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex. J Clin Microbiol 1997 1.04
33 Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clin Infect Dis 1992 1.02
34 Mycobacterium tuberculosis lineage: a naming of the parts. Tuberculosis (Edinb) 2005 1.01
35 Re-emergence of tuberculosis. BMJ 1993 1.00
36 Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010 0.99
37 New methods in the diagnosis and management of cerebral toxoplasmosis associated with the acquired immune deficiency syndrome. J Infect 1991 0.98
38 Think TB! Is the diagnosis of pulmonary tuberculosis delayed by the use of antibiotics? Int J Tuberc Lung Dis 2009 0.97
39 Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture. J Med Microbiol 2010 0.96
40 Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic. J Med Microbiol 2002 0.95
41 Sexually transmitted diseases in prostitutes in Moshi and Arusha, Northern Tanzania. Int J STD AIDS 1992 0.95
42 Audit of laboratory diagnostic methods for syphilis in England and Wales. Sex Transm Infect 2008 0.91
43 Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics. J Antimicrob Chemother 1988 0.90
44 A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory. J Med Microbiol 2007 0.90
45 Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue. Tuberculosis (Edinb) 2008 0.87
46 Investigation of a choline phosphate synthesis pathway in Streptococcus pneumoniae: evidence for choline phosphate cytidylyltransferase activity. FEMS Microbiol Lett 1996 0.87
47 The interpretation of nucleic acid amplification tests for tuberculosis: do rapid tests change treatment decisions? J Infect 2005 0.87
48 Early predictors of mortality in pneumococcal bacteraemia. J Infect 2000 0.86
49 Toxocariasis: a practical approach to management of ocular disease. Eye (Lond) 1988 0.86
50 Approaches to measure the fitness of Burkholderia cepacia complex isolates. J Med Microbiol 2010 0.86
51 Detection of circulating parasite antigen and specific antibody in Toxocara canis infections. Clin Exp Immunol 1988 0.86
52 Managing malaria in tuberculosis patients on fluoroquinolone-containing regimens: assessing the risk of QT prolongation. Int J Tuberc Lung Dis 2012 0.86
53 Bacillus cereus peritonitis in a patient being treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997 0.84
54 Fluoroquinolone-resistant mutants of Burkholderia cepacia. Antimicrob Agents Chemother 2007 0.84
55 Meningitis due to oral streptococci following percutaneous glycerol rhizotomy of the trigeminal ganglion. J Infect 1995 0.84
56 The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function. J Antimicrob Chemother 2008 0.84
57 Incorporation of choline into Streptococcus pneumoniae cell wall antigens: evidence for choline kinase activity. FEMS Microbiol Lett 1996 0.84
58 How valid is single-colony isolation for surveillance of Streptococcus pneumoniae carriage? J Clin Microbiol 2008 0.83
59 The serum rifabutin concentrations in a patient successfully treated for multi-resistant Mycobacterium tuberculosis infection. J Antimicrob Chemother 1990 0.83
60 Malaria in Northern Ireland. Ulster Med J 1986 0.83
61 Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania. Ann Trop Med Parasitol 2006 0.83
62 Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models. Vaccine 2007 0.82
63 International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. J Antimicrob Chemother 1993 0.81
64 A field evaluation of the formol-detergent method for concentrating faecal parasites. J Trop Med Hyg 1991 0.81
65 Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Int J Antimicrob Agents 2004 0.81
66 Weight as a surrogate marker of treatment response in tuberculosis. Int J Tuberc Lung Dis 1998 0.80
67 When is an outbreak not an outbreak? Fit, divergent strains of Mycobacterium tuberculosis display independent evolution of drug resistance in a large London outbreak. J Antimicrob Chemother 2012 0.80
68 Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis. J Antimicrob Chemother 1993 0.79
69 In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors. J Antimicrob Chemother 1987 0.78
70 Clinical features and serum beta 2-microglobulin levels in HIV-1 positive and negative Tanzanian patients with tuberculosis. Int J STD AIDS 1995 0.77
71 Pneumococcal bacteraemia. Lancet 1991 0.77
72 Monitoring the therapy of pulmonary tuberculosis by nested polymerase chain reaction. J Infect 1997 0.77
73 Is there a relationship between Mycobacterium tuberculosis strain type and TB paradoxical reaction? Thorax 2005 0.76
74 Hatching of second-stage larvae of Toxocara canis: a rapid method for processing large numbers of worms. J Helminthol 1991 0.76
75 Cholera: getting the message across. BMJ 1992 0.75
76 Early bactericidal activity as a method of assessment of drugs for the treatment of tuberculosis. J Antimicrob Chemother 1994 0.75
77 Acute infectious erythemas in children. Br J Dermatol 1992 0.75
78 Treatment of tuberculosis in HIV infection. Tuber Lung Dis 1993 0.75
79 The prevalence of Toxocara canis ova in soil samples from parks and gardens in the London area. Public Health 1992 0.75
80 Meningitis in an Irish community. Ulster Med J 1988 0.75
81 Rapid diagnosis of whooping cough using monoclonal antibody. J Clin Pathol 1988 0.75
82 Streptococcus pneumoniae choline binding proteins. Role in cell wall turnover. Adv Exp Med Biol 1997 0.75
83 DIY microbiology. BMJ 1991 0.75
84 Cryptococcal cholangitis: a novel presentation of disseminated cryptococcosis in AIDS. Int J STD AIDS 1997 0.75
85 Evaluation of the safety and efficacy of micronized halofantrine in the treatment of semi-immune patients with acute, Plasmodium falciparum malaria. Ann Trop Med Parasitol 1996 0.75
86 RP59500 (Quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium. J Infect 1998 0.75
87 Antibiotic susceptibility of Enterobacteriaceae isolated from patients in northern Tanzania. J Antimicrob Chemother 1992 0.75
88 Brodie's abscess caused by Eikenella corrodens. J Infect 1991 0.75
89 A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens. J Antimicrob Chemother 1994 0.75
90 Molecular strain typing of M. tuberculosis isolates from a suspected outbreak involving a faulty bronchoscope. J Hosp Infect 2005 0.75
91 Are patients on treatment for pulmonary TB who stop expectorating sputum genuinely culture negative? Thorax 2009 0.75
92 Estimation of mutation rates in antibiotic research. Methods Mol Med 2001 0.75
93 Multidrug-resistant tuberculosis. Br J Hosp Med 1995 0.75
94 Neonatal campylobacter enteritis with secondary lactose intolerance. Acta Paediatr Scand 1988 0.75